How Nemifitide diTFA can Save You Time, Stress, and Money.
MI-CP151 was a stage 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre examine To guage many intravenous doses of sifalimumab, in Grownup people with dermatomyositis or polymyositis (NCT00533091). Most important trial objectives had been to evaluate the security and tolerability of sifalimumab in dermatomyositis or polym